1244 — 3D Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	—	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	414	824	942	997	841
Net Total Accounts Receivable
Net Total Receivables	10.6	72.3	156	85	49.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	462	919	1,143	1,095	988
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26.8	119	178	193	148
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	496	1,060	1,332	1,429	1,216
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	315	3,248	376	500	488
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1,766	3,298	389	492	431
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-1,270	-2,238	943	937	785
Total Liabilities & Shareholders' Equity	496	1,060	1,332	1,429	1,216
Total Common Shares Outstanding